Regulatory Deadline Board/2026-06660
Food and Drug Administration · Notice
Electronic Submission of Postmarketing Individual Case Safety Reports to the Food and Drug Administration Adverse Event Monitoring System Using International Council of Harmonisation E2B(R3) Data Standards; Regional Data Elements and Implementation Schedule
Closed 29 days ago
- Agency
- Food and Drug Administration
- Document type
- Notice
- Published
- Apr 6, 2026
- Comments close
- Oct 1, 2026
- Status
- Closed 29 days ago
- Federal Register number
- 2026-06660
- Docket
- Docket No. FDA-2016-D-1280
More from Food and Drug Administration
Notice · 59 days left
Electronic Submission Template for Investigational Device Exemption (IDE) Applications; Draft Guidance for Sponsors and Food and Drug Administration Staff; Availability
Proposed Rule · 38 days left
Nonclinical Testing Terminology
Rule · 38 days left
Nonclinical Testing Terminology
Notice · 31 days left
Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards
Notice · 28 days left
Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management; Draft Guidance for Industry; Availability
Notice · 18 days left
Electronic Submission Template for Medical Device Premarket Approval Applications (PMAs); Draft Guidance for Industry and Food and Drug Administration Staff; Availability